Lv51
980 积分 2022-10-28 加入
Optimal retreatment schedule of rituximab for neuromyelitis optica spectrum disorder: A systematic review
12天前
已完结
Early rituximab treatment reduces long-term disability in aquaporin-4 antibody-positive neuromyelitis optica spectrum
12天前
已完结
Efficacy and Safety of Monoclonal Antibody Therapy in Neuromyelitis Optica Spectrum Disorders: Evidence from Randomized Controlled Trials
12天前
已完结
FCGR3A-V158F Gene Polymorphism: A potential Predictor for Rituximab Dosing Optimization in Chinese Patients with Neuromyelitis Optica Spectrum Disorder
12天前
已完结
Different doses of Rituximab for the therapy of Neuromyelitis optica spectrum disorder: A systematic review and meta-analysis
12天前
已完结
Immune-Mediated Myelopathies
2个月前
已完结
The Daratumumab Crosses the Blood Brain Barrier
2个月前
已完结
Irregular degree centrality in neuromyelitis optica spectrum disorder patients with optic neuritis: A resting-state functional magnetic resonance imaging study
3个月前
已完结
Irregular degree centrality in neuromyelitis optica spectrum disorder patients with optic neuritis: A resting-state functional magnetic resonance imaging study
3个月前
已完结
A Novel Anti-CD38 Monoclonal Antibody for Treating Immune Thrombocytopenia
3个月前
已完结
皖公网安备34019202002308
